Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Tracy L. Skaer & Winghan Jacqueline Kwong. (2017) Illness perceptions and burden of disease in fibromyalgia. Expert Review of Pharmacoeconomics & Outcomes Research 17:1, pages 9-15.
Read now
Read now
Caitlyn T Solem, Ahmed Shelbaya, Yin Wan, Chinmay G Deshpande, Jose Alvir & Elizabeth Pappadopulos. (2016) Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data. Neuropsychiatric Disease and Treatment 12, pages 2755-2764.
Read now
Read now
Margaret Tiktin, Selda Celik & Lori Berard. (2016) Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review. Current Medical Research and Opinion 32:2, pages 277-287.
Read now
Read now
Stefan Wilhelm, Frank G Boess, Ulrich Hegerl, Roland Mergl, Michael Linden, Alexander Schacht & Edith Schneider. (2012) Tolerability aspects in duloxetine-treated patients with depression: should one use a lower starting dose in clinical practice?. Expert Opinion on Drug Safety 11:5, pages 699-711.
Read now
Read now
Xianchen Liu, Yi Chen & Douglas E Faries. (2011) Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder. ClinicoEconomics and Outcomes Research 3, pages 63-72.
Read now
Read now
Articles from other publishers (16)
Mark S. Nestor, Alec Lawson & Daniel Fischer. (2023) Improving the mental health and well-being of healthcare providers using the transcendental meditation technique during the COVID-19 pandemic: A parallel population study. PLOS ONE 18:3, pages e0265046.
Crossref
Crossref
Muritala Hamdalat Folake & Bewaji Clement Olatubosun. (2021) Paroxetine Administration Alter some Biochemical Parameters in Male Wistar Rats Over a Systemic Period of Thirty-Five Days. Nigerian Journal of Pure and Applied Sciences, pages 3899-3914.
Crossref
Crossref
Sanjay Vasant Kamble, Salman Abdulrehman Motlekar, Lyndon Lincoln D'souza, Vinay Nanda Kudrigikar & Sameer Eknath Rao. (2017) Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?. The Korean Journal of Pain 30:3, pages 183-191.
Crossref
Crossref
Anat Fisher, Greg Carney, Ken Bassett & Neena L. Chappell. (2016) Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation. Value in Health 19:5, pages 688-696.
Crossref
Crossref
Kathryn A. Martinez, Angela Fagerlin, Holly O. Witteman, Christine Holmberg & Sarah T. Hawley. (2015) What Matters to Women When Making Decisions About Breast Cancer Chemoprevention?. The Patient - Patient-Centered Outcomes Research 9:2, pages 149-159.
Crossref
Crossref
Yifei LiuChunlin QianMei Yang. (2016) Treatment Patterns Associated with ACR-Recommended Medications in the Management of Fibromyalgia in the United States. Journal of Managed Care & Specialty Pharmacy 22:3, pages 263-271.
Crossref
Crossref
Ronald S. Oosting, Johnny S. Chan, Berend Olivier, Pradeep Banerjee, Yong Kee Choi & Frank Tarazi. (2016) Differential effects of vilazodone versus citalopram and paroxetine on sexual behaviors and serotonin transporter and receptors in male rats. Psychopharmacology 233:6, pages 1025-1034.
Crossref
Crossref
Peter Meulenbeek, Kristin Seeger & Peter M. ten Klooster. (2015) Dropout prediction in a public mental health intervention for sub-threshold and mild panic disorder. The Cognitive Behaviour Therapist 8.
Crossref
Crossref
W. J. Sandborn, S. D. Lee, C. Randall, A. Gutierrez, D. A. Schwartz, S. Ambarkhane, C. Kayhan, B. Pierre-Louis, S. Schreiber & G. R. Lichtenstein. (2014) Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study. Alimentary Pharmacology & Therapeutics 40:8, pages 903-916.
Crossref
Crossref
Ignacio Párraga Martínez, Jesús López-Torres Hidalgo, José M. del Campo del Campo, Alejandro Villena Ferrer, Susana Morena Rayo & Francisco Escobar Rabadán. (2014) Seguimiento de la adherencia al tratamiento antidepresivo en pacientes que inician su consumo. Atención Primaria 46:7, pages 357-366.
Crossref
Crossref
A. R. Mahableshwarkar, P. L. Jacobsen, Y. Chen & J. S. Simon. (2014) A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder. International Journal of Clinical Practice 68:1, pages 49-59.
Crossref
Crossref
Monika Salgueiro, Xabier Basogain, Antonio Collado, Xavier Torres, Juan Bilbao, Francisco Doñate, Luciano Aguilera & Jon Jatsu Azkue. (2013) An Artificial Neural Network Approach for Predicting Functional Outcome in Fibromyalgia Syndrome after Multidisciplinary Pain Program. Pain Medicine 14:10, pages 1450-1460.
Crossref
Crossref
Chi-Shin Wu, Wen-Yi Shau, Hung-Yu Chan & Mei-Shu Lai. (2013) Persistence of antidepressant treatment for depressive disorder in Taiwan. General Hospital Psychiatry 35:3, pages 279-285.
Crossref
Crossref
Allison J. Applebaum, Wendy G. Lichtenthal, Hayley A. Pessin, Julia N. Radomski, N. Simay Gökbayrak, Aviva M. Katz, Barry Rosenfeld & William Breitbart. (2012) Factors associated with attrition from a randomized controlled trial of meaning-centered group psychotherapy for patients with advanced cancer. Psycho-Oncology 21:11, pages 1195-1204.
Crossref
Crossref
Steve Gelwicks, Douglas E. Faries & Xianchen Liu. (2011) Predictors of Duloxetine Treatment Persistence for Patients with Major Depressive Disorder. Health Outcomes Research in Medicine 2:1, pages e3-e13.
Crossref
Crossref
Xianchen Liu, Steve Gelwicks, Douglas E. Faries & Stephen L. Able. (2010) Initial duloxetine prescription dose and treatment adherence and persistence in patients with major depressive disorder. International Clinical Psychopharmacology 25:6, pages 315-322.
Crossref
Crossref